Emergent Biosolutions, Inc. (EBS) is trading at $6.21 down 0.32% over the past 24 hours. Its Galaxy Score is 60.9, LunarCrush's combined measure of market and social performance. Over the last 24 hours it has seen 544 engagements and 15 posts with 100% positive social sentiment.
AI summary: Emergent BioSolutions Inc. (EBS) biodefense vaccine developer tied to PAHPA-funded ACAM2000 contract amid policy timing uncertainty. Contract win supports near-term deliveries, but policy timing uncertainty caps upside and keeps shares near 52-week lows.